GlassScriptPhysician profile
Tony T Bui
NPI 1427093418
$245.45
in general payments reported to CMS, 2019-2025
6 companies · $18.61 in 2025
The $18.61 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.18 · 2021: $15.36 · 2022: $17.83 · 2023: $147 · 2024: $33.01 · 2025: $18.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $88.76 | 2023 | Rexulti, Nuedexta |
| Lundbeck LLC | $60.91 | 2023-2025 | Rexulti |
| Avanir Pharmaceuticals, INC. | $33.19 | 2021-2022 | |
| Depuy Synthes Sales INC. | $32.00 | 2023-2024 | Monovisc, Orthovisc |
| Aimmune Therapeutics, INC. | $17.41 | 2024 | |
| Acadia Pharmaceuticals INC | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tony Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.